REFERENCES
- Levy N S, Crapps E E. Displacement of optic nerve head in response to short-term intraocular pressure elevation in human eyes. Arch Ophthalmol. 1984; 102: 782–786, [PUBMED], [INFOTRIEVE]
- Gaasterland D, Tanishima T, Kuwabara T. Axoplasmic flow during chronic experimental glaucoma. 1. Light and electron microscopic studies of the monkey optic nervehead during development of glaucomatous cupping. Invest Ophthalmol Vis Sci. 1978; 17: 838–846, [PUBMED], [INFOTRIEVE]
- Minckler D S, Spaeth G L. Optic nerve damage in glaucoma. Surv Ophthalmol. 1981; 26: 128–148, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Quigley H A, Hohman R M, Addicks E M, Massof R W, Green W R. Morphologic changes in the lamina cribrosa correlated with neural loss in open-angle glaucoma. Am J Ophthalmol. 1983; 95: 673–691, [PUBMED], [INFOTRIEVE]
- Morgan J E. Optic nerve head structure in glaucoma: astrocytes as mediators of axonal damage. Eye 2000; 14: 437–444, [PUBMED], [INFOTRIEVE]
- Quigley H A. Ganglion cell death in glaucoma: pathology recapitulates ontogeny. Aust N Z J Ophthalmol. 1995; 23: 85–91, [PUBMED], [INFOTRIEVE], [CSA]
- Quigley H A, McKinnon S J, Zack D J, Pease M E, Kerrigan-Baumrind L A, Kerrigan D F, Mitchell R S. Retrograde axonal transport of BDNF in retinal ganglion cells is blocked by acute IOP elevation in rats. Invest Ophthalmol Vis Sci. 2000; 41: 3460–3466, [PUBMED], [INFOTRIEVE], [CSA]
- Wang N, Zeng M, Ruan Y, Wu H, Chen J, Fan Z, Zhen H. Protection of retinal ganglion cells against glaucomatous neuropathy by neurotrophin-producing, genetically modified neural progenitor cells in a rat model. Chin Med J (Engl). 2002; 11: 1394–400
- Osborne N N, Melena J, Chidlow G, Wood J P. A hypothesis to explain ganglion cell death caused by vascular insults at the optic nerve head: possible implication for the treatment of glaucoma. Br J Ophthalmol. 2001; 85: 1252–1259, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Flammer J, Orgul S. Optic nerve blood-flow abnormalities in glaucoma. Prog Retin Eye Res. 1998; 17: 267–289, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Phelps C D, Corbett J J. Migraine and low-tension glaucoma. A case-control study. Invest Ophthalmol Vis Sci. 1985; 26: 1105–1108, [PUBMED], [INFOTRIEVE]
- Grunwald J E, Piltz J, Hariprasad S M, DuPont J. Optic nerve and choroidal circulation in glaucoma. Invest Ophthalmol Vis Sci. 1998; 39: 2329–2336, [PUBMED], [INFOTRIEVE], [CSA]
- Yamazaki Y, Drance S M. The relationship between progression of visual field defects and retrobulbar circulation in patients with glaucoma. Am J Ophthalmol. 1997; 124: 287–295, [PUBMED], [INFOTRIEVE], [CSA]
- Drance S M, Douglas G R, Wijsman K, Schulzer M, Britton R J. Response of blood flow to warm and cold in normal and low-tension glaucoma patients. Am J Ophthalmol. 1988; 105: 35–39, [PUBMED], [INFOTRIEVE]
- Dkhissi O, Chanut E, Wasowicz M, Savoldelli M, Nguyen-Legros J, Minvielle F, Versaux-Botteri C. Retinal TUNEL-positive cells and high glutamate levels in vitreous humor of mutant quail with a glaucoma-like disorder. Invest Ophthalmol Vis Sci. 1999; 40: 990–995, [PUBMED], [INFOTRIEVE], [CSA]
- Martin K R, Levkovitch-Verbin H, Valenta D, Baumrind L, Pease M E, Quigley H A. Retinal glutamate transporter changes in experimental glaucoma and after optic nerve transection in the rat. Invest Ophthalmol Vis Sci. 2002; 43: 2236–2243, [PUBMED], [INFOTRIEVE], [CSA]
- Brooks D E, Garcia G A, Dreyer E B, Zurakowski D, Franco-Bourland R E. Vitreous body glutamate concentration in dogs with glaucoma. Am J Vet Res. 1997; 58: 864–867, [PUBMED], [INFOTRIEVE], [CSA]
- Carter-Dawson L, Shen F, Harwerth R S, Smith E L, 3rd, Crawford M L, Chuang A. Glutamine immunoreactivity in Muller cells of monkey eyes with experimental glaucoma. Exp Eye Res. 1998; 66: 537–545, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Netland P A, Chaturvedi N, Dreyer E B. Calcium channel blockers in the management of low-tension and open-angle glaucoma. Am J Ophthalmol. 1993; 116: 778–780, [CSA]
- Piltz J R, Bose S, Lanchoney D. The effects of nimodipine, a centrally active calcium antagonist, on visual function and macular blood flow in patients with normal-tension glaucoma and control subjects. J Glaucoma. 1998; 7: 336–342, [PUBMED], [INFOTRIEVE], [CSA]
- Koseki N, Araie M, Yamagami J, Shirato S, Yamamoto S. Effects of oral brovincamine on visual field damage in patients with normal-tension glaucoma with low-normal intraocular pressure. J Glaucoma. 1999; 8: 117–123, [PUBMED], [INFOTRIEVE], [CSA]
- Sawada A, Kitazawa Y, Yamamoto T, Okabe I, Ichien K. Prevention of visual field defect progression with brovincamine in eyes with normal-tension glaucoma. Ophthalmology 1996; 103: 283–288, [PUBMED], [INFOTRIEVE], [CSA]
- Toriu N, Akaike A, Yasuyoshi H, Zhang S, Kashii S, Honda Y, Shimazawa M, Hara H. Lomerizine, a Ca2+ channel blocker, reduces glutamate-induced neurotoxicity and ischemia/reperfusion damage in rat retina. Exp Eye Res. 2000; 70: 475–484, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Takahashi K, Lam T T, Edward D P, Buchi E R, Tso M O. Protective effects of flunarizine on ischemic injury in the rat retina. Arch Ophthalmol. 1992; 110: 862–870, [PUBMED], [INFOTRIEVE]
- Shirahase H, Wada K, Uehara Y, Nakamura S, Ichikawa A. Preventive effect of iganidipine on renal and cerebral injuries in salt-induced hypertension. Am J Hypertens 1997; 10: 869–878, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Osborne N N, Wood J P, Cupido A, Melena J, Chidlow G. Topical flunarizine reduces IOP and protects the retina against ischemia-excitotoxicity. Invest Ophthalmol Vis Sci. 2002; 43: 1456–1464, [PUBMED], [INFOTRIEVE], [CSA]
- Kanda M, Shirahase H, Kurahashi K, Wada K, Nakamura S, Matsui H. et al. Effect of the novel water-soluble calcium antagonist(±)-3-(4-allyl-1-piperazinyl)-2,2-dimethylpropyl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate dihydrochloride on the responses of isolated canine arteries. Arzneim-Forsch/Drug Res. 1995; 45: 831–835, [CSA]
- Ishii K, Matsuo H, Fukaya Y, Tanaka S, Sakaki H, Waki M, Araie M. Iganidipine, a new water-soluble Ca2+ antagonist: ocular and periocular penetration after instillation. Invest Ophthalmol Vis Sci. 2003; 44: 1169–1177, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Thulin T. Calcium antagonists—assessment of side effects. Scand J Prim Health Care Suppl. 1990; 1: 81–4, [PUBMED], [INFOTRIEVE]
- Larach D R, Zelis R. Advances in calcium blocker therapy. Am J Surg. 1986; 151: 527–537, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Morizane C, Adachi K, Furutani I, Fujita Y, Akaike A, Kashii S, Honda Y. N(omega)-nitro-L-arginine methyl ester protects retinal neurons against N-methyl-D-aspartate-induced neurotoxicity in vivo. Eur J Pharmacol. 1997; 328: 45–49, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Mizota A, Sato E, Taniai M, Adachi-Usami E, Nishikawa M. Protective effects of dietary docosahexaenoic acid against kainate-induced retinal degeneration in rats. Invest Ophthalmol Vis Sci. 2001; 42: 216–221, [PUBMED], [INFOTRIEVE], [CSA]
- Nash M S, Osborne N N. Assessment of Thy-1 mRNA levels as an index of retinal ganglion cell damage. Invest Ophthalmol Vis Sci. 1999; 40: 1293–1298, [PUBMED], [INFOTRIEVE], [CSA]
- Mizuno K, Koide T, Yoshimura M, Araie M. Neuroprotective effect and intraocular penetration of nipradilol, a beta-blocker with nitric oxide donative action. Invest Ophthalmol Vis Sci. 2001; 42: 688–694, [PUBMED], [INFOTRIEVE], [CSA]
- Vorwerk C K, Lipton S A, Zurakowski D, Hyman B T, Sabel B A, Dreyer E B. Chronic low-dose glutamate is toxic to retinal ganglion cells. Toxicity blocked by memantine. Invest Ophthalmol Vis Sci. 1996; 37: 1618–1624, [PUBMED], [INFOTRIEVE], [CSA]
- Honjo M, Tanihara H, Kido N, Inatani M, Okazaki K, Honda Y. Expression of ciliary neurotrophic factor activated by retinal Muller cells in eyes with NMDA- and kainic acid-induced neuronal death. Invest Ophthalmol Vis Sci. 2000; 41: 552–560, [PUBMED], [INFOTRIEVE], [CSA]
- Nichol K A, Schulz M W, Bennett M R. Nitric oxide-mediated death of cultured neonatal retinal ganglion cells: neuroprotective properties of glutamate and chondroitin sulfate proteoglycan. Brain Res. 1995; 697: 1–16, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Selles-Navarro I, Villegas-Perez M P, Salvador-Silva M, Ruiz-Gomez J M, Vidal-Sanz M. Retinal ganglion cell death after different transient periods of pressure-induced ischemia and survival intervals. A quantitative in vivo study. Invest Ophthalmol Vis Sci. 1996; 37: 2002–2014, [PUBMED], [INFOTRIEVE], [CSA]
- Li S, Mizota A, Adachi, Usami E. Alterations of the electroretinogram by intravitreous kainic acid in the rat. Jpn J Ophthalmol. 1999; 43: 495–501, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Hughes W F. Quantitation of ischemic damage in the rat retina. Exp Eye Res. 1991; 53: 573–582, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Weber M, Bonaventure N, Sahel J A. Protective role of excitatory amino acid antagonists in experimental retinal ischemia. Graefes Arch Clin Exp Ophthalmol. 1995; 233: 360–365, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Vidal-Sanz M, Lafuente M P, Mayor-Torroglosa S, Aguilera M E, Miralles de Imperial J, Villegas-Perez M P. Brimonidine's neuroprotective effects against transient ischaemia-induced retinal ganglion cell death. Eur J Ophthalmol. 2001; 11: 36–40
- Sawada A, Neufeld A H. Confirmation of the rat model of chronic, moderately elevated intraocular pressure. Exp Eye Res. 1999; 69: 525–531, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Schuettauf F, Naskar R, Vorwerk C K, Zurakowski D, Dreyer E B. Ganglion cell loss after optic nerve crush mediated through AMPA-kainate and NMDA receptors. Invest Ophthalmol Vis Sci. 2000; 41: 4313–4316, [PUBMED], [INFOTRIEVE], [CSA]
- Dingledine R, Borges K, Bowie D, Traynelis S F. The glutamate receptor ion channels. Pharmacol Rev. 1999; 51: 7–61, [PUBMED], [INFOTRIEVE]
- Brandstatter J H, Koulen P, Wassle H. Diversity of glutamate receptors in the mammalian retina. Vision Res. 1998; 38: 1385–1397, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Murphy S N, Miller R J. Regulation of Ca++ influx into striatal neurons by kainic acid. J Pharmacol Exp Ther. 1989; 249: 184–193, [PUBMED], [INFOTRIEVE], [CSA]
- Ferreira I L, Duarte C B, Carvalho A P. Ca2+ influx through glutamate receptor-associated channels in retina cells correlates with neuronal cell death. Eur J Pharmacol. 1996; 302: 153–162, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Frandsen A, Schousboe A. Mobilization of dantrolene-sensitive intracellular calcium pools is involved in the cytotoxicity induced by quisqualate and N-methyl-D-aspartate but not by 2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionate and kainate in cultured cerebral cortical neurons. Proc Natl Acad Sci USA. 1992; 89: 2590–2594, [PUBMED], [INFOTRIEVE], [CSA]
- Eimerl S, Schramm M. An endogenous metal appears to regulate NMDA receptor mediated Ca influx and toxicity in cultured cerebellar granule cells. Neurosci Lett. 1992; 137: 198–202, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Hartley D M, Kurth M C, Bjerkness L, Weiss J H, Choi D W. Glutamate receptor-induced Ca2 + accumulation in cortical cell culture correlates with subsequent neuronal degeneration. J Neurosci. 1993; 13: 1993–2000, [PUBMED], [INFOTRIEVE]
- Otori Y, Kusaka S, Kawasaki A, Morimura H, Miki A, Tano Y. Protective effect of nilvadipine against glutamate neurotoxicity in purified retinal ganglion cells. Brain Res. 2003; 961: 213–219, [PUBMED], [INFOTRIEVE]
- Akaike N, Ishibashi H, Hara H, Oyama Y, Ueha T. Effect of KB-2796, a new diphenylpiperazine Ca2+ antagonist, on voltage-dependent Ca2+ currents and oxidative metabolism in dissociated mammalian CNS neurons. Brain Res. 1993; 619: 263–270, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Otori Y, Wei J Y, Barnstable C J. Neurotoxic effects of low doses of glutamate on purified rat retinal ganglion cells. Invest Ophthalmol Vis Sci. 1998; 39, 972-581
- Lam T T, Abler A S, Kwong J M, Tso M O. N-methyl-D-aspartate (NMDA)–induced apoptosis in rat retina. Invest Ophthalmol Vis Sci. 1999; 40, 2391-239
- Calzada J I, Jones B E, Netland P A, Johnson D A. Glutamate-induced excitotoxicity in retina: neuroprotection with receptor antagonist, dextromethorphan, but not with calcium channel blockers. Neurochem Res. 2002; 27: 79–88, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]